Medtronic (MDT) Receivables (2014 - 2026)

Medtronic has disclosed Receivables across 13 years of filings, most recently posting $6.4 billion for Q1 2026.

• Receivables for Q1 2026 came in at $6.4 billion, up 3.99% year-over-year; the trailing twelve-month figure through Jan 2026 was $6.4 billion (up 3.99% YoY), and the FY2025 annual result was $6.5 billion, up 6.32% from the prior year.
• Receivables came in at $6.4 billion for Q1 2026 at Medtronic, roughly flat from $6.4 billion in the prior quarter.
• In the past five years, Receivables ranged from a high of $6.5 billion in Q2 2025 to a low of $5.3 billion in Q3 2022.
• The 5-year median for Receivables is $6.0 billion (2023), against an average of $6.0 billion.
• Across the five-year window, Receivables decreased 2.26% in 2022 and climbed 9.38% in 2023, its largest moves.
• Medtronic's Receivables stood at $5.6 billion in 2022, then gained by 5.47% to $5.9 billion in 2023, then advanced by 5.49% to $6.3 billion in 2024, then grew by 2.06% to $6.4 billion in 2025, then retreated by 0.47% to $6.4 billion in 2026.
• The last three Receivables figures came in at $6.4 billion (Q1 2026), $6.4 billion (Q4 2025), and $6.3 billion (Q3 2025), per Business Quant data.